Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

Authors:

Abstract
No abstract available
Funding Information
  • Leukemia and Lymphoma Society
  • Bristol Myers Squibb
  • Lymphoma Research Foundation
  • American Society of Hematology

This publication has 13 references indexed in Scilit: